Clinical Research Informer

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Rethinking Clinical Trials

MARCH 6, 2024

Food-as-Medicine observational studies have had a large correlation with improved health. Clinic staff included a dietitian, a nurse and a community health worker. Additional data sources came from EHR data, health plan claims, and program participation data including food visits and education.

Clinical Trials

Clinical Trials Clinical Trials Medicine Trials

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Rethinking Clinical Trials

JULY 14, 2023

Tyson School of Medicine Slides Keywords Pragmatic Clinical Trial, GGC4H, Prevention Key Points Guiding Good Choices for Health Study (GGC4H) is about the Guiding Good Choices (GGC) intervention, a group-based program for parents and caregivers of younger adolescents (ages 9-14). 2) Can virtual GGC be delivered with fidelity?

Clinical Trials

Clinical Trials Clinical Trials Trials Research

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

pharmaphorum

APRIL 26, 2021

Using technologies such as VR and AI, the company aims to accelerate human growth and social rehabilitation in medical education and provide support for people with disabilities, as well as provide treatments for mental illness. The post Jolly Good/Teijin Pharma develop VR digital therapeutics for depression appeared first on.

Development

Development Medicine Production Marketing

Grand Rounds May 5, 2023: All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine (Joshua C. Denny, MD, MS)

Rethinking Clinical Trials

MAY 10, 2023

Denny, MD, MS CEO, All of Us Research Program Slides Keywords Precision Medicine, All of Us Research Program Key Points The mission of the All of Us Research Program is to accelerate health research and medical breakthroughs, enabling individualized prevention, treatment, and care for all of us. We are looking forward to supporting more.

Medicine

Medicine Research Clinical Trials Clinical Trials

Pear claims breakthrough tag for alcohol use disorder DTx

pharmaphorum

NOVEMBER 24, 2021

Digital health company Pear Therapeutics has won FDA breakthrough device status for reSET-A, its development-stage prescription digital therapeutic (DTx) for people with alcohol-use disorder. The post Pear claims breakthrough tag for alcohol use disorder DTx appeared first on. Photo by thom masat on Unsplash.

Production

Production Development Trials

Kim Sledge and the World We Want partner with WHO Foundation to re-record unity anthem “We Are Family” in response to COVID-19 and to focus on global public health needs

The Pharma Data

OCTOBER 19, 2020

Special edition cover of the classic song “We Are Family’ will be accompanied by a worldwide viral video starring celebrities, frontline health heroes, leaders and members of the public singing together in a show of solidarity and support for addressing present and future global public health needs, including COVID-19.

Scientist

Scientist Nurses Doctors Doctor

Grand Rounds Ethics and Regulatory Series October 14, 2022: Responding (or Not) to Signals of Potential Clinical Significance in Pragmatic Clinical Trials (Joseph Ali, JD; Tanya Matthews, PhD; Leslie J. Crofford, MD)

Rethinking Clinical Trials

OCTOBER 19, 2022

of International Health. Johns Hopkins Bloomberg School of Public Health. These data increasingly include info that might signal physical, mental health or behavioral health risks to patient-subjects (e.g. ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ? ?. Speakers. Joseph Ali, JD.

Clinical Trials

Clinical Trials Clinical Trials Trials Medicine

A history of Johnson & Johnson

pharmaphorum

FEBRUARY 26, 2021

Between 1896 and 1897, J&J enabled a huge step forward for women’s health when it manufactured the first mass-produced sanitary protection products. For all the latest pharma news on Johnson & Johnson, follow pharmaphorum’s J&J and Janssen tags. The post A history of Johnson & Johnson appeared first on.

Sales

Sales Production Pharma Companies Marketing

With an $11 billion price tag, the White House pitches a plan to end hepatitis C

STAT News

MARCH 9, 2023

It’s a significant price tag for a single line in the broader budget request; while the $11 billion ask would cover five years of the new initiative, it still dwarfs the annual budget request for the entire Food and Drug Administration, at $7.2 billion.

Drugs

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

MAY 5, 2021

AbbVie’s Humira regains top pharma TV spender spot, while sibling brands Rinvoq and Skyrizi tag along ( Fierce ). Inside Vida Health’s $110M Series D & Big Push into Digital Mental Health ( The Health Care Blog ). Medtech. Government & Regulatory.

Vaccination

Vaccination Vaccine Gene Therapy Contract Packaging

Clinical Research Informer

Grand Rounds March 1, 2024: Effect of an Intensive Food-As-Medicine Program on Health and Health Care Use: Evidence from a Randomized Clinical Trial (Joseph Doyle, PhD)

Grand Rounds March 3, 2023: Adoption, Implementation and Sustainment of Family-focused Prevention in Health Care Systems: How Do We Get There? (Margaret Kuklinski, PhD; Stacy Sterling, DrPH, MSW)

Trending Sources

Jolly Good/Teijin Pharma develop VR digital therapeutics for depression

Grand Rounds May 5, 2023: All of Us Research Program: Improving Health Through Diverse Technology, Huge Cohorts, and Precision Medicine (Joshua C. Denny, MD, MS)

Pear claims breakthrough tag for alcohol use disorder DTx

Kim Sledge and the World We Want partner with WHO Foundation to re-record unity anthem “We Are Family” in response to COVID-19 and to focus on global public health needs

Grand Rounds Ethics and Regulatory Series October 14, 2022: Responding (or Not) to Signals of Potential Clinical Significance in Pragmatic Clinical Trials (Joseph Ali, JD; Tanya Matthews, PhD; Leslie J. Crofford, MD)

A history of Johnson & Johnson

With an $11 billion price tag, the White House pitches a plan to end hepatitis C

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

Stay Connected